- Home
- EVG vs DERM Comparison
EVG vs DERM Comparison
Compare EVG & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVG
- DERM
- Stock Information
- Founded
- EVG 2005
- DERM 2014
- Country
- EVG United States
- DERM United States
- Employees
- EVG N/A
- DERM N/A
- Industry
- EVG Investment Managers
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- EVG Finance
- DERM Health Care
- Exchange
- EVG Nasdaq
- DERM Nasdaq
- Market Cap
- EVG 146.4M
- DERM 181.0M
- IPO Year
- EVG N/A
- DERM 2021
- Fundamental
- Price
- EVG $10.79
- DERM $8.06
- Analyst Decision
- EVG
- DERM Strong Buy
- Analyst Count
- EVG 0
- DERM 2
- Target Price
- EVG N/A
- DERM $10.00
- AVG Volume (30 Days)
- EVG 49.4K
- DERM 103.3K
- Earning Date
- EVG 01-01-0001
- DERM 05-14-2025
- Dividend Yield
- EVG 8.68%
- DERM N/A
- EPS Growth
- EVG N/A
- DERM N/A
- EPS
- EVG N/A
- DERM N/A
- Revenue
- EVG N/A
- DERM $56,243,000.00
- Revenue This Year
- EVG N/A
- DERM $29.83
- Revenue Next Year
- EVG N/A
- DERM $54.88
- P/E Ratio
- EVG N/A
- DERM N/A
- Revenue Growth
- EVG N/A
- DERM N/A
- 52 Week Low
- EVG $9.13
- DERM $3.54
- 52 Week High
- EVG $10.86
- DERM $8.24
- Technical
- Relative Strength Index (RSI)
- EVG 49.46
- DERM 65.90
- Support Level
- EVG $10.71
- DERM $6.55
- Resistance Level
- EVG $10.90
- DERM $7.00
- Average True Range (ATR)
- EVG 0.12
- DERM 0.63
- MACD
- EVG -0.01
- DERM 0.13
- Stochastic Oscillator
- EVG 38.24
- DERM 92.41
About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest
Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.